Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Center For Pediatric And Adolescent Medicine Of The Johannes Gutenberg University Mainz

Verifiedinfo

Germany Langenbeckstrasse 1, Oberstadt, 55131 Mainz, Germany

  • 196 trials recruiting
  • Acute myeloid leukaemia · Systemic lupus erythematosus · Metabolic dysfunction-associated steatohepatitis
  • Adults and children

About Specializations

Center For Pediatric And Adolescent Medicine Of The Johannes Gutenberg University Mainz in Mainz, Germany specialises in clinical trials of conditions such as Acute myeloid leukaemia, Systemic lupus erythematosus, Metabolic dysfunction-associated steatohepatitis, Hidradenitis, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms Research in Pediatric Hematology/Oncology

At the Center For Pediatric And Adolescent Medicine Of The Johannes Gutenberg University Mainz, clinical research focuses on malignant extracranial germ cell tumours within the broader field of neoplasms. The studies are aimed at improving treatment choices for children and adolescents affected by these rare cancers.

  • Evaluating whether one chemotherapy option can match the effectiveness of another for malignant germ cell tumours
  • Comparing treatment approaches to support better event-free survival in patients with intermediate, high, and very high risk disease
  • Advancing care for extracranial malignant germ cell tumours through research on treatment effectiveness

The site in Mainz contributes to cancer research that is both clinically focused and highly specialized, with an emphasis on finding better ways to treat rare pediatric and adolescent tumors.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Langenbeckstrasse 1, Oberstadt55131 MainzGermany
Open in maps ↗
Recruiting now
196 trials
Conditions studied
254
Partner status
Verified

More sites in MainzGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

501 clinical trials

A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis

Recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

Non-small cell lung cancer stage I

Recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Mrna-4157
  • Sponsor:Merck Sharp & Dohme LLC

Systemic lupus erythematosus

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anifrolumab
  • Sponsor:AstraZeneca AB

Renal disorder

Recruiting
Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.

Metabolic dysfunction-associated steatohepatitis+1

Recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH

Metabolic dysfunction-associated steatohepatitis+1

Recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH

Focal segmental glomerulosclerosis

Recruiting
Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.

Breast cancer

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:BioNTech SE

Small cell lung cancer+2

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:BioNTech SE

Psoriasis

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Pancreatic neuroendocrine tumour

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Exelixis Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.